| Roche Forays in Rare Diseases by Licensing PTC Therapeutics’ Spinal Muscular Atrophy Programme |
Abstract
|
|
Heather Cartwright |
|
| Servier Options MacroGenics’ Phase I Cancer Immunotherapy |
Abstract
|
|
Heather Cartwright |
|
| India’s Lupin Expands its Presence In Japan with I’rom Pharmaceutical Acquisition |
Abstract
|
|
Heather Cartwright |
|
| Gilead Bets on Pharmasset with US$11 B Acquisition Agreement |
Abstract
|
|
Heather Cartwright |
|
| Pfizer Gains Phase II Skin Fibrosis Drug with Excaliard Acquisition |
Abstract
|
|
Heather Cartwright |
|
| AstraZeneca Strengthens its Position in China with Guangdong BeiKang Pharmaceutical Acquisition |
Abstract
|
|
Heather Cartwright |
|
| Biogen Idec Enters Biosimilars Market via Joint Venture with Samsung Biologics |
Abstract
|
|
Heather Cartwright |
|